Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
DRTS

Alpha Tau Medical (DRTS) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $14.41 +2.9% on the day +272.4% over 12 months 52-week range $3.47 – $15.50

Share price and insider trades

DRTS closeInsider buyInsider sale
05101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $27,694 on 2026-07-01 · Raphi LevySold $31,780 on 2026-07-06 · Raphi LevySold $43,065 on 2026-08-21 · Raphi LevySold $167,050 on 2026-06-23 · Raphi LevySold $220,000 on 2026-06-25 · Raphi LevySold $232,349 on 2026-07-02 · Raphi LevySold $240,000 on 2026-06-30 · Raphi LevySold $248,220 on 2026-08-11 · Raphi LevySold $352,150 on 2026-06-03 · Raphi Levy
Bought, 12 months$0
Sold, 12 months$1.6M
Insiders buying0
Insiders selling1

Alpha Tau Medical insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $1.6M of DRTS stock on the open market.

DRTS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $979K sold (7 trades)Q2 2026Q3 2026: $583K sold (5 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$583K5
Q2 2026—0$979K7

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Alpha Tau Medical Ltd. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $1.6M. 10 of 12 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 25SEC Raphi LevyCFO Sell Plan 2,87190,180 held (−3%) $15.00 $43K -3.9% —
Aug 12SEC Raphi LevyCFO Sell Plan 17,73090,180 held (−16%) $14.00 $248K +2.9% —
Jul 7SEC Raphi LevyCFO Sell Plan 2,27090,180 held (−2%) $14.00 $32K +2.9% —
Jul 6SEC Raphi LevyCFO Sell Plan 17,87390,180 held (−17%) $13.00 $232K +10.8% —
Jul 2SEC Raphi LevyCFO Sell Plan 2,12790,180 held (−2%) $13.02 $28K +10.7% —
Jul 1SEC Raphi LevyCFO Sell Plan 20,00090,180 held (−18%) $12.00 $240K +20.1% —
Jun 26SEC Raphi LevyCFO Sell Plan 15,778110,180 held (−13%) $11.00 $174K +31.0% —
Jun 26SEC Raphi LevyCFO Sell Plan 4,222125,958 held (−3%) $11.00 $46K +31.0% —
Jun 25SEC Raphi LevyCFO Sell Plan 15,000132,680 held (−10%) $9.47 $142K +52.2% —
Jun 25SEC Raphi LevyCFO Sell Plan 2,500130,180 held (−2%) $10.00 $25K +44.1% —
Jun 4SEC Raphi LevyCFO Sell 17,500162,680 held (−10%) $10.90 $191K +32.2% —
Jun 4SEC Raphi LevyCFO Sell 15,000147,680 held (−9%) $10.76 $161K +33.9% —

Insiders at Alpha Tau Medical Ltd.

InsiderBoughtSoldLast filingScore
Raphi LevyCFO — $1.6M Aug 25, 2026 —

DRTS stock: common questions

Are Alpha Tau Medical Ltd. insiders buying DRTS stock?

In the past 12 months, 0 insiders reported open-market purchases of DRTS worth $0.

Are Alpha Tau Medical Ltd. insiders selling DRTS stock?

1 insiders reported sales worth $1.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is DRTS's 52-week range?

Over the past year DRTS has traded between $3.47 and $15.50. It last closed at $14.41 on Oct 9, 2026.